ישראל - עברית - Ministry of Health

kamada ltd, israel - rupatadine as fumarate - תמיסה - rupatadine as fumarate 1 mg / 1 ml - rupatadine

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - olopatadine as hydrochloride - טיפות עיניים - olopatadine as hydrochloride 1 mg / 1 ml - olopatadine

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - loratadine - סירופ - loratadine 0.1 g / 100 ml - loratadine

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - loratadine - סירופ - loratadine 0.1 g / 100 ml - loratadine

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - clofarabine - תרכיז להכנת תמיסה לאינפוזיה - clofarabine 1 mg / 1 ml - clofarabine

ישראל - עברית - Ministry of Health

teva israel ltd - loratadine - טבליה - loratadine 10 mg - other antihistamines for systemic use - relief of symptoms of allergy in seasonal allergic rhinitis, perennial allergic rhihitis, chronic urticaria.

ישראל - עברית - Ministry of Health

bayer israel ltd - loratadine - טבליה - loratadine 10 mg - other antihistamines for systemic use - seasonal allergic rhinitis, perennial allergic rhinitis, chronic urticaria.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - desloratadine 0.5 mg/ml - syrup - desloratadine - for the relief of symptoms associated with : allergic rhinitis (ar) and chronic idiopathic urticaria (ciu) in adults and children 1 year of age and above.

ישראל - עברית - Ministry of Health

inovamed ltd - desloratadine 5 mg - film coated tablets - desloratadine - for the relief of symptoms associated with: allergic rhinitis, urticaria.

ישראל - עברית - Ministry of Health

sanofi - aventis israel ltd - clofarabine 1 mg/ml - concentrate for solution for infusion - clofarabine - treatment of acute lymphoblastic leukaemia (all) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and who are about to undergo transplantation. safety and efficacy have been assessed in studies of patients < or = 21 years old at initial diagnosis .